Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Corrigendum to "p85 beta-PIX is required for cell motility through phosphorylations of focal adhesion kinase and p38 MAP kinase"[Exp. Cell Res. 307(2) (2005) 315-328].

Lee J, Jung ID, Chang WK, Park CG, Cho DY, Shin EY, Seo DW, Kim YK, Lee HW, Han JW, Lee HY.

Exp Cell Res. 2019 Jun 15;379(2):245-247. doi: 10.1016/j.yexcr.2019.03.030. Epub 2019 Apr 13. No abstract available.

PMID:
30992206
2.

Repositioning of the antipsychotic drug TFP for sepsis treatment.

Park JH, Park HJ, Lee SE, Kim YS, Jang GY, Han HD, Jung ID, Shin KC, Bae YM, Kang TH, Park YM.

J Mol Med (Berl). 2019 May;97(5):647-658. doi: 10.1007/s00109-019-01762-4. Epub 2019 Mar 8.

PMID:
30848296
3.

Development of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis.

Kim J, Jacob B, Jang M, Kwak C, Lee Y, Son K, Lee S, Jung ID, Jeong MS, Kwon SH, Kim Y.

Sci Rep. 2019 Mar 7;9(1):3817. doi: 10.1038/s41598-019-40577-8.

4.

Enhanced Expression and Functional Characterization of the Recombinant Putative Lysozyme-PMAP36 Fusion Protein.

Rao Z, Kim SY, Akanda MR, Lee SJ, Jung ID, Park BY, Kamala-Kannan S, Hur J, Park JH.

Mol Cells. 2019 Mar 31;42(3):262-269. doi: 10.14348/molcells.2019.2365. Epub 2019 Feb 19.

5.

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.

Park HJ, Jang GY, Kim YS, Park JH, Lee SE, Vo MC, Lee JJ, Han HD, Jung ID, Kang TH, Park YM.

J Immunother Cancer. 2019 Feb 28;7(1):60. doi: 10.1186/s40425-019-0539-7.

6.

Vildagliptin, an Anti-diabetic Drug of the DPP-4 Inhibitor, Induces Vasodilation via Kv Channel and SERCA Pump Activation in Aortic Smooth Muscle.

Seo MS, Li H, An JR, Jung ID, Jung WK, Ha KS, Han ET, Hong SH, Choi IW, Park WS.

Cardiovasc Toxicol. 2019 Jun;19(3):244-254. doi: 10.1007/s12012-018-9496-5.

PMID:
30519910
7.

A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells.

Kim YS, Park HJ, Park JH, Hong EJ, Jang GY, Jung ID, Han HD, Lee SH, Vo MC, Lee JJ, Yang A, Farmer E, Wu TC, Kang TH, Park YM.

Oncoimmunology. 2018 Aug 15;7(10):e1472187. doi: 10.1080/2162402X.2018.1472187. eCollection 2018.

PMID:
30288341
8.

CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.

Byeon Y, Lee JW, Choi WS, Won JE, Kim GH, Kim MG, Wi TI, Lee JM, Kang TH, Jung ID, Cho YJ, Ahn HJ, Shin BC, Lee YJ, Sood AK, Han HD, Park YM.

Cancer Res. 2018 Nov 1;78(21):6247-6256. doi: 10.1158/0008-5472.CAN-17-3871. Epub 2018 Aug 16.

PMID:
30115698
9.

Phloretin as a Potent Natural TLR2/1 Inhibitor Suppresses TLR2-Induced Inflammation.

Kim J, Durai P, Jeon D, Jung ID, Lee SJ, Park YM, Kim Y.

Nutrients. 2018 Jul 5;10(7). pii: E868. doi: 10.3390/nu10070868.

10.

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.

Kim GH, Won JE, Byeon Y, Kim MG, Wi TI, Lee JM, Park YY, Lee JW, Kang TH, Jung ID, Shin BC, Ahn HJ, Lee YJ, Sood AK, Han HD, Park YM.

Drug Deliv. 2018 Nov;25(1):1394-1402. doi: 10.1080/10717544.2018.1480672.

11.

Tamarixetin Exhibits Anti-inflammatory Activity and Prevents Bacterial Sepsis by Increasing IL-10 Production.

Park HJ, Lee SJ, Cho J, Gharbi A, Han HD, Kang TH, Kim Y, Lee Y, Park WS, Jung ID, Park YM.

J Nat Prod. 2018 Jun 22;81(6):1435-1443. doi: 10.1021/acs.jnatprod.8b00155. Epub 2018 May 31.

12.

Mycobacterium tuberculosis GrpE, A Heat-Shock Stress Responsive Chaperone, Promotes Th1-Biased T Cell Immune Response via TLR4-Mediated Activation of Dendritic Cells.

Kim WS, Jung ID, Kim JS, Kim HM, Kwon KW, Park YM, Shin SJ.

Front Cell Infect Microbiol. 2018 Mar 27;8:95. doi: 10.3389/fcimb.2018.00095. eCollection 2018.

13.

Inhibitory effect of the tricyclic antidepressant amitriptyline on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.

Li H, Shin SE, Seo MS, An JR, Ha KS, Han ET, Hong SH, Choi IW, Lee DS, Yim MJ, Lee JM, Jung ID, Firth AL, Han IY, Park WS.

Clin Exp Pharmacol Physiol. 2018 Feb;45(2):205-212. doi: 10.1111/1440-1681.12857. Epub 2017 Nov 8.

PMID:
28945283
14.

An Essential Role for TAGLN2 in Phagocytosis of Lipopolysaccharide-activated Macrophages.

Kim HR, Lee HS, Lee KS, Jung ID, Kwon MS, Kim CH, Kim SM, Yoon MH, Park YM, Lee SM, Jun CD.

Sci Rep. 2017 Aug 18;7(1):8731. doi: 10.1038/s41598-017-09144-x.

15.

Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity.

Jeon D, Jeong MC, Jacob B, Bang JK, Kim EH, Cheong C, Jung ID, Park Y, Kim Y.

Sci Rep. 2017 May 3;7(1):1455. doi: 10.1038/s41598-017-01474-0.

16.

Neoagarooligosaccharides prevent septic shock by modulating A20-and cyclooxygenase-2-mediated interleukin-10 secretion in a septic-shock mouse model.

Kang DR, Yoon GY, Cho J, Lee SJ, Lee SJ, Park HJ, Kang TH, Han HD, Park WS, Yoon YK, Park YM, Jung ID.

Biochem Biophys Res Commun. 2017 May 13;486(4):998-1004. doi: 10.1016/j.bbrc.2017.03.152. Epub 2017 Mar 28.

PMID:
28363868
17.

Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity.

Lee MH, Jang JH, Yoon GY, Lee SJ, Lee MG, Kang TH, Han HD, Kim HS, Choi WS, Park WS, Park YM, Jung ID.

BMB Rep. 2017 May;50(5):263-268.

18.

Phloretin Exerts Anti-Tuberculosis Activity and Suppresses Lung Inflammation.

Jeon D, Jeong MC, Jnawali HN, Kwak C, Ryoo S, Jung ID, Kim Y.

Molecules. 2017 Jan 22;22(1). pii: E183. doi: 10.3390/molecules22010183.

19.

Platelet-activating Factor Mediates Endotoxin Tolerance by Regulating Indoleamine 2,3-Dioxygenase-dependent Expression of the Suppressor of Cytokine Signaling 3.

Noh KT, Jung ID, Cha GS, Han MK, Park YM.

J Biol Chem. 2017 Feb 24;292(8):3290-3298. doi: 10.1074/jbc.M116.764464. Epub 2017 Jan 11.

20.

In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy.

Han HD, Byeon Y, Jang JH, Jeon HN, Kim GH, Kim MG, Pack CG, Kang TH, Jung ID, Lim YT, Lee YJ, Lee JW, Shin BC, Ahn HJ, Sood AK, Park YM.

Sci Rep. 2016 Dec 2;6:38348. doi: 10.1038/srep38348.

Supplemental Content

Loading ...
Support Center